We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Home2024-10-02T10:25:57+02:00

BIOmarker based diagnostic TOOLkit to personalize pharmacological approaches in congestive heart failure

BIOTOOL-CHF Project Video

0
Partners
0
Duration
0
EU Contribution

Project

The innovation potential of BIOTOOL-CHF is built on the overall approach that will be adopted to tackle the unsolved issue of improving the efficiency of fluid management in systolic heart failure

Objectives

BIOTOOL-CHF will discover, develop, and validate a personalised approach to manage diuretic therapy in heart failure and reduced ejection fraction, to reduce heart failure hospitalizations and improve quality of life

Impacts

BIOTOOL-CHF gathers major European heart failure and big data analysis experts to provide an innovative approach to the management patients with heart failure and reduced ejection fraction, which is one of the most frequent, costly and deadly pathological conditions in Europe

RecentNews

Forthcoming Events

BIOTOOL-CHF  2nd Workshop 
Belgrade | 17 May 2025

Heart-Failure-Congress-Visual_escardio-PosterEI

Find out more >>

Latest news

PARTNERS INVOLVED

BIOTOOL-CHF partners join forces to change the paradigm of heart failure with reduced ejection fraction pharmacological therapy, by developing a personalised strategy to target congestion with diuretics.

Project Details

PROJECT NUMBER: 101095653
PROJECT TITLE: BIOmarker based diagnostic TOOLkit to personalize pharmacological approaches in congestive heart failure
TOPIC: HORIZON-HLTH-2022-TOOL-11-01
START DATE: 1 October 2023
DURATION: 60 Months
GRANTING AUTHORITY: HADEA
EU CONTRIBUTION: 9.600.663,00 Euro

Follow Us!

“Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do notnecessarily reflect those of the European Union or the European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.”

Copyright 2023 BIOTOOL-CHF | All Rights Reserved | Powered by WarrantHub S.p.A.

Go to Top